DarioHealth Corp.

Ticker(s):

DRIO

Country:

Sector & Industry:

,
Business Overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Contact & Other Information

Number of Employees:

249

322 W 57th St
#33B
New York

,

NY

,

10019
United States
03/14/2025 | 8-K | 0001104659-25-023589 |

DarioHealth Corp. engaged Kesselman & Kesselman (PwC) as its new independent registered public accounting firm and dismissed Kost, Forer, Gabbay & Kasierer (EY).